« previous next »
Pages: [1]

Author Topic: Study uncovers potential risks of beta interferon treatment (Avonex, Betaseron, Rebif, Extavia)  (Read 86 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
Study uncovers potential risks of beta interferon treatment (Avonex, Betaseron, Rebif, Extavia)
« on: March 07, 2018, 03:58:01 pm »
From MS Focus, a publication of the MS Foundation. The article concerns a study in the journal Neurology about possible risks of the beta interferon drugs in the treatment of MS:


https://msfocus.org/About-Us/MSF-News-Articles/54


The Neurology article (June 13, 2017)--"Evaluating the safety of beta-interferons in MS"--is available:


http://n.neurology.org/content/88/24/2310
« Last Edit: March 07, 2018, 04:08:43 pm by agate »
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
119 Views 		Last post May 18, 2017, 04:38:01 pm
by agate
0 Replies
261 Views 		Last post July 25, 2017, 08:57:52 pm
by agate
0 Replies
218 Views 		Last post July 25, 2017, 09:03:33 pm
by agate
0 Replies
107 Views 		Last post December 29, 2018, 04:21:30 pm
by agate
0 Replies
40 Views 		Last post December 21, 2021, 06:20:24 am
by agate